PCN62 Cost-Effectiveness Analysis of First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia
Jun 1, 2012, 00:00 AM
10.1016/j.jval.2012.03.1179
https://www.valueinhealthjournal.com/article/S1098-3015(12)01244-2/fulltext
Section Title :
Cancer
Section Order :
704
First Page :
A219
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01244-2&doi=10.1016/j.jval.2012.03.1179